ISTH DIC Score: Standardized diagnostic criteria for overt Disseminated Intravascular Coagulation. Requires an underlying disorder associated with DIC.
Platelets (× 10³/µL)
D-dimer / FDP Increase
PT Prolongation (sec)
Fibrinogen (g/L)
Cumulative DIC Score
0
Non-Overt / No DIC
Score < 5. Suggest repeat labs in 24 hours if clinical condition worsens.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Clinically suspected Disseminated Intravascular Coagulation (DIC) in patients with an underlying disorder known to be associated with DIC (e.g., sepsis, trauma, malignancy, obstetric complications).
To objectively verify the presence of overt (decompensated) DIC.
Monitoring disease progression and response to treatment in critical illness.
Patient Population
Applicable only to patients who have an "underlying disorder" associated with DIC. Without an established trigger, the score has no diagnostic utility.
When Not to Rely on This Score Alone
Non-overt (compensated) DIC — requires a separate scoring system for early phase detection.
Chronic DIC — often seen in malignancy/aneurysms; laboratory parameters may be normal or near-normal despite consumption.
Liver failure — low platelets and high PT may reflect impaired synthesis rather than consumptive coagulopathy (though they often co-exist).
Section 2
Formula & Logic
Scoring Variables
Variable
Criteria
Weight
Platelets (× 10³/µL)
> 100
0
50 - 100
1
< 50
2
PT Prolongation (sec)
< 3
0
3 - 6
1
> 6
2
Fibrinogen (g/L)
> 1.0
0
< 1.0
1
Soluble Fibrin / D-dimer
No increase
0
Moderate increase
2
Strong increase
3
Section 3
Pearls/Pitfalls
The Fibrinogen Paradox
Fibrinogen is an acute-phase reactant. In many cases of sepsis, it may be elevated. A "normal" fibrinogen level in a patient with multi-organ failure and low platelets may actually represent a pathologically "low" level due to consumption.
Overt DIC Threshold
A score ≥ 5 is compatible with overt DIC. Sensitivity 91%, Specificity 97%. If the score is < 5, suggest repeating labs in 24 hours if clinical suspicion persists.
Section 4
Evidence Appraisal
Consensus Criteria
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.
Taylor FB et al. • Thrombosis and Haemostasis. 2001;86(5):1327-30.
The International Society on Thrombosis and Haemostasis (ISTH) Subcommittee on DIC developed this system to address the clinical ambiguity surrounding the diagnosis of "consumptive coagulopathy."